Insulin resistance and dyslipidaemia in obese premenopausal and postmenopausal women matched for leg/trunk fat mass ratio

References

• Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, Willet WC, Manson JE. Abdominal adiposity and coronary heart disease in women. J Am Med Assoc 1998; 280: 1843–8
   PubMed Web of Science ®Google Scholar
• Kanaya AM, Vittinghoff E, Shlipak MG, Resnick HE, Visser M, Grady D, Barret‐Connor E. Association of total and central obesity with mortality in postmenopausal women with coronary heart disease. Am J Epidemiol 2003; 158: 1161–70
   PubMed Web of Science ®Google Scholar
• Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, Speizer FE, Manson JE. Body fat distribution and risk of non‐insulin‐dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol 1997; 145: 614–19
   PubMed Web of Science ®Google Scholar
• Toth MJ, Tchernof A, Sites CK, Poehlman ET. Menopause‐related changes in body fat distribution. Ann NY Acad Sci 2000; 904: 502–6
   PubMed Web of Science ®Google Scholar
• Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Int Med 1995; 123: 673–5
   PubMed Web of Science ®Google Scholar
• Svendsen OL, Hassager C, Christiansen C. Age‐ and menopause‐associated variations in body composition and fat distribution in healthy women as measured by dual‐energy X‐ray absorptiometry. Metabolism 1995; 44: 369–73
   PubMed Web of Science ®Google Scholar
• Tremolieres FA, Pouilles JM, Ribot CA. Relative influence of age and menopause on total and regional body composition changes in postmenopausal women. Am J Obstet Gynecol 1996; 175: 1594–600
   PubMed Web of Science ®Google Scholar
• Ley CJ, Lees B, Stevenson JC. Sex‐ and menopause‐associated changes in body‐fat distribution. Am J Clin Nutr 1992; 55: 950–4
   PubMed Web of Science ®Google Scholar
• Panotopoulos G, Ruiz JC, Raison C, Guy‐Grand B, Basdevant A. Menopause, fat and lean distribution in obese women. Maturitas 1996; 25: 11–19
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, Orlandi R, Genazzani AR. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 1997; 82: 414–17
   PubMed Web of Science ®Google Scholar
• Toth MJ, Sites CK, Eltabbakh GH, Poehlman ET. Effect of menopausal status on insulin‐stimulated glucose disposal. Comparison of middle‐aged premenopausal and early postmenopausal women. Diabetes Care 2000; 23: 801–6
   PubMed Web of Science ®Google Scholar
• DeNino WF, Tchernof A, Dionne I, Toth MJ, Ades PA, Sites CK, Poehlman ET. Contribution of abdominal adiposity to age‐related differences in insulin sensitivity and plasma lipids in healthy non‐obese women. Diabetes Care 2001; 24: 925–32
   PubMed Web of Science ®Google Scholar
• Van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, Kohrt WM. Contribution of total and regional fat mass to risk for cardiovascular disease in older women. Am J Physiol Endocrinol Metab 2002; 282: E1023–8
   PubMed Web of Science ®Google Scholar
• Van Pelt RE, Jankowski CM, Gozansky WS, Schwartz RS, Kohrt WM. Lower‐body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab 2005; 90: 4573–8
   PubMed Web of Science ®Google Scholar
• Tatsukawa M, Kurokawa M, Tamari Y, Yoshimatsu H, Sakata T. Regional fat deposition in the legs is useful as a presumptive marker of antiatherogenisity. Japanese Proc Soc Exp Bio Med 2000; 223: 156–62
   PubMed Web of Science ®Google Scholar
• Tankó LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 2003; 107: 1626–31
   PubMed Web of Science ®Google Scholar
• Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Yudkin JS, Heine RJ, Nijpels G, Seidell JC. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels. Diabetes Care 2004; 27: 372–7
   PubMed Web of Science ®Google Scholar
• Aasen G, Fagertun H, Halse J. Body composition analysis by dual X‐ray absorptiometry: in vivo and in vitro comparison of three different fan‐beam instruments. Scand J Clin Lab Invest 2006; 66: 659–66
   PubMed Web of Science ®Google Scholar
• Aasen G, Fagertun H, Halse J. Regional fat mass by DXA: high leg fat mass attenuates the relative risk of insulin resistance and dyslipidemia in obese but not in overweight postmenopausal women. Scand J Clin Lab Invest 2008; 68: 204–11
   PubMed Web of Science ®Google Scholar
• Aasen G, Fagertun H, Halse J. Leg fat mass measured by dual X‐ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus men. Scand J Clin Lab Invest, Epub ahead of publication (2008).
   Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Maylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta‐cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–19
   PubMed Web of Science ®Google Scholar
• Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggianai F, Zenner MB, Monauni T, Muggero M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000; 23: 57–63
   PubMed Web of Science ®Google Scholar
• Katz A, Nambi SS, Mather K, Baron AD, Follman DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402–10
   PubMed Web of Science ®Google Scholar
• Yokoyama H, Emoto M, Fujiwara S, Motomyama K, Morioka T, Komatsu M, Tahara H, Shoji T, Nishizawa Y. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal weight range and moderately obese type 2 diabetic patients. Diabetes Care 2003; 26: 426–32
   Web of Science ®Google Scholar
• Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Jarvinen HY, Van Haften T, Renn W, Gerich J. Use of the oral tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23: 295–301
   PubMed Web of Science ®Google Scholar
• Friedewald WR, Levy RI, Fredichson DS. Estimation of the concentration of low‐density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Pascot A, Lemieux S, Lemieux I, Prud'homme D, Tremblay A, Bouchard C, Nadeau A, Couillard C, Tchernof A, Bergeron J, Despres J‐P. Age‐related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care 1999; 22: 1471–8
   PubMed Web of Science ®Google Scholar
• Ferranini E, Vichi S, Beck‐Nielsen H, Laakso M, Paolisso G, Smith U. European Group for the Study of Insulin Resistance (EGIR): Insulin action and age. Diabetes 1999; 45: 947–53
   Google Scholar
• Tchernof A, Poehlman ET, Despres J-P. Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab (Paris) 2000; 26: 12–20
   PubMed Web of Science ®Google Scholar
• Brochu M, Mathieu ME, Karelis ED, Doucet E, Lavoie ME, Garrel D, Rabasa‐Lhoret R. Contribution to the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study. Obesity (Silver Spring) 2008; 16: 1085–93
   PubMed Web of Science ®Google Scholar
• Goulet ED, Lord C, Chaput JP, Aubertin‐Leheudre M, Brochu M, Dionne IJ. No difference in insulin sensitivity between healthy postmenopausal women with or without sarcopenia: a pilot study. Appl Physiol Nutr Metab 2007; 32: 426–33
   PubMed Web of Science ®Google Scholar
• Aubertin-Leheudre M, Lord C, Goulet ED, Dionne IJ. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity (Silver Spring) 2006; 14: 2277–83
   PubMed Web of Science ®Google Scholar
• Svendsen OL, Hassager C, Christiansen C. Relationships and independence of body composition, sex hormones, fat distribution and other cardiovascular risk factors in overweight postmenopausal women. Int J Obes 1993; 17: 459–63
   PubMed Web of Science ®Google Scholar
• Tchernof A, Toth MJ, Poehlman ET. Sex hormone‐binding globulin levels in middle‐aged premenopausal women. Diabetes Care 1999; 22: 1875–81
   PubMed Web of Science ®Google Scholar
• Nestler JE. Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance (Editorial). J Clin Endocrinol Metab 1993; 76: 273–4
   PubMed Web of Science ®Google Scholar
• Preziosi P, Barrett-Connor E, Papoz L, Roger M, Saint-Paul M, Nahoul K, Simon D. Interrelation between plasma sex hormone binding globulin and plasma insulin in healthy adult women: the Telecom study. J Clin Endocrinol Metab 1993; 76: 283–7
   PubMed Web of Science ®Google Scholar
• Weinberg ME, Manson JE, Buring JE, Cook N, Seely EW, Ridker PM, Rexrode KM. Low sex-hormone binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism 2006; 55: 1473–80
   PubMed Web of Science ®Google Scholar
• Munoz J, Derstine A, Gower BA. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement. Obes Res 2002; 10: 424–31
   PubMedGoogle Scholar
• Paradisi G, Smith L, Burtner C, Leaming R, Garvey WT, Hook G, Johnson A, Cronin J, Steinberg HO, Baron AD. Dual energy X‐ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care 1999; 22: 1310–17
   PubMed Web of Science ®Google Scholar
• Ferrara CM, Lynch NA, Nicklas BJ, Ryan AS, Merman DM. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab 2002; 87: 4166–70
   PubMed Web of Science ®Google Scholar
• Ricart W, Fernandez‐Real J‐M. No decrease in free IGF‐1 with increasing insulin in obesity-related insulin resistance. Obes Res 2001; 9: 631–6
   PubMedGoogle Scholar
• Gomez JM, Maravall FJ, Gomez N, Navarro MA, Casamitjana R, Soler J, The IG. F‐1 system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat. Growth Horm IGF Res 2004; 14: 91–6
   PubMed Web of Science ®Google Scholar
• Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB. Effect of obesity on total and free insulin‐like growth factor (IGF‐1), and their relationship to IG F‐binding protein (BP)‐1, IGFB‐2, IGFB‐3, insulin and growth hormone. Int J Obes 1997; 21: 355–9
   PubMed Web of Science ®Google Scholar
• Hanley AJG, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance of cardiovascular disease. The San Antonio Heart Study. Diabetes Care 2002; 25: 1177–84
   PubMed Web of Science ®Google Scholar